ST-segment elevation myocardial infarction (STEMI) is the most acute manifestation of coronary artery disease and is associated with great morbidity and mortality. A complete …
GW Reed, JE Rossi, CP Cannon - The Lancet, 2017 - thelancet.com
Acute myocardial infarction has traditionally been divided into ST elevation or non-ST elevation myocardial infarction; however, therapies are similar between the two, and the …
S Bangalore, S Kumar, M Fusaro, N Amoroso… - Circulation, 2012 - Am Heart Assoc
Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade; however, the relative short-and long-term efficacy and safety of DES compared with bare …
M Sabate, A Cequier, A Iñiguez, A Serra… - The Lancet, 2012 - thelancet.com
Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …
Background Mechanical reperfusion with stenting for ST-elevation myocardial infarction (STEMI) is supported by dual antiplatelet treatment with aspirin and clopidogrel. Prasugrel, a …
C Stettler, S Wandel, S Allemann, A Kastrati… - The Lancet, 2007 - thelancet.com
Background Whether the two drug-eluting stents approved by the US Food and Drug Administration—a sirolimus-eluting stent and a paclitaxel-eluting stent—are associated with …
S Garg, PW Serruys - Journal of the American College of Cardiology, 2010 - jacc.org
Coronary artery stents revolutionized the practice of interventional cardiology after they were first introduced in the mid-1980s. Since then, there have been significant developments in …
SB King III, SC Smith Jr, JW Hirshfeld Jr, AK Jacobs… - Circulation, 2008 - Am Heart Assoc
Interventions. Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www. acc. org), American Heart Association (my …